NM_004640.7:c.64G>A

Variant names:

• chr6-31540469-C-T
• NM_004640.7:c.64G>A

Variant summary

Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2 BP4_Moderate

The NM_004640.7(DDX39B):​c.64G>A​(p.Ala22Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

• Frequency: Genomes: not found (cov: 32)
• Consequence: DDX39B NM_004640.7 missense
• Clinical Significance: Not reported in ClinVar
• Conservation: PhyloP100: 3.41

Genes affected

DDX39B (HGNC:13917): (DExD-box helicase 39B) This gene encodes a member of the DEAD box family of RNA-dependent ATPases that mediate ATP hydrolysis during pre-mRNA splicing. The encoded protein is an essential splicing factor required for association of U2 small nuclear ribonucleoprotein with pre-mRNA, and it also plays an important role in mRNA export from the nucleus to the cytoplasm. This gene belongs to a cluster of genes localized in the vicinity of the genes encoding tumor necrosis factor alpha and tumor necrosis factor beta. These genes are all within the human major histocompatibility complex class III region. Mutations in this gene may be associated with rheumatoid arthritis. Alternative splicing results in multiple transcript variants. Related pseudogenes have been identified on both chromosomes 6 and 11. Read-through transcription also occurs between this gene and the upstream ATP6V1G2 (ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G2) gene. [provided by RefSeq, Feb 2011]

ATP6V1G2-DDX39B (HGNC:41999): (ATP6V1G2-DDX39B readthrough (NMD candidate)) This locus represents naturally occurring read-through transcription between the neighboring ATP6V1G2 (ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G2) and DDX39B (DEAD box polypeptide 39B) genes located in the major histocompatibility complex class III region of chromosome 6. The read-through transcript and is a candidate for nonsense-mediated mRNA decay (NMD), and is thus unlikely to produce a protein product. [provided by RefSeq, Feb 2011]

ACMG classification

Verdict is Uncertain_significance. Variant got 0 ACMG points.

• PM2: Very rare variant in population databases, with high coverage
• BP4: Computational evidence support a benign effect (MetaRNN=0.14696208).

Transcripts

RefSeq

Gene	Transcript	HGVSc	HGVSp	Effect	Exon rank	MANE	Protein	UniProt
DDX39B	NM_004640.7	c.64G>A	p.Ala22Thr	missense_variant	Exon 2 of 11	ENST00000396172.6	NP_004631.1
DDX39B	NM_080598.6	c.64G>A	p.Ala22Thr	missense_variant	Exon 2 of 11		NP_542165.1
DDX39B	NR_037852.2	n.250G>A		non_coding_transcript_exon_variant	Exon 2 of 9
ATP6V1G2-DDX39B	NR_037853.1	n.867G>A		non_coding_transcript_exon_variant	Exon 4 of 13

Ensembl

Gene	Transcript	HGVSc	HGVSp	Effect	Exon rank	TSL	MANE	Protein	Appris	UniProt
DDX39B	ENST00000396172.6	c.64G>A	p.Ala22Thr	missense_variant	Exon 2 of 11	1	NM_004640.7	ENSP00000379475.1
ATP6V1G2-DDX39B	ENST00000376185.5	n.*278G>A		non_coding_transcript_exon_variant	Exon 4 of 13	2		ENSP00000365356.1
ATP6V1G2-DDX39B	ENST00000376185.5	n.*278G>A		3_prime_UTR_variant	Exon 4 of 13	2		ENSP00000365356.1

Frequencies

GnomAD3 genomes Cov.: 32

GnomAD4 exome Cov.: 31

GnomAD4 genome Cov.: 32

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name	Calibrated prediction	Score	Prediction
AlphaMissense	Benign	0.068
BayesDel_addAF	Benign	-0.11	T
BayesDel_noAF	Benign	-0.39
CADD	Benign	23
DANN	Uncertain	1.0
DEOGEN2	Benign	0.0089	T;T;T;.;.;.;T;.;T;T;.;T
Eigen	Benign	-0.13
Eigen_PC	Benign	0.094
FATHMM_MKL	Uncertain	0.88	D
M_CAP	Benign	0.0090	T
MetaRNN	Benign	0.15	T;T;T;T;T;T;T;T;T;T;T;T
MetaSVM	Benign	-1.1	T
MutationAssessor	Benign	0.57	.;N;N;.;.;.;.;.;.;.;.;.
PrimateAI	Uncertain	0.63	T
PROVEAN	Benign	-0.32	N;N;N;N;N;N;N;N;N;N;N;N
REVEL	Benign	0.067
Sift	Benign	0.24	T;T;T;T;T;T;T;T;T;T;T;T
Sift4G	Benign	0.18	T;T;T;T;T;.;.;T;.;.;.;.
Polyphen		0.0010	B;B;B;.;.;.;.;.;.;.;.;.
Vest4		0.28
MutPred		0.17		Gain of phosphorylation at A22 (P = 0.0269);Gain of phosphorylation at A22 (P = 0.0269);Gain of phosphorylation at A22 (P = 0.0269);Gain of phosphorylation at A22 (P = 0.0269);Gain of phosphorylation at A22 (P = 0.0269);Gain of phosphorylation at A22 (P = 0.0269);Gain of phosphorylation at A22 (P = 0.0269);Gain of phosphorylation at A22 (P = 0.0269);.;Gain of phosphorylation at A22 (P = 0.0269);.;Gain of phosphorylation at A22 (P = 0.0269);
MVP		0.48
MPC		1.4
ClinPred		0.72	D
GERP RS		5.5
Varity_R		0.14
gMVP		0.56

Splicing

Name	Calibrated prediction	Score	Prediction
SpliceAI score (max)		0.020		Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

No publications associated with this variant yet.

Other links and lift over

hg19: chr6-31508246;